Browsing by Author "Farré Albaladejo, Magí"

Sort by: Order: Results:

  • Keller, Benjamin; Mestre-Pintó, Juan Ignacio; Álvaro-Bartolomé, María; Martínez-Sanvisens, Diana; Farré Albaladejo, Magí; García-Fuster, M. Julia; García Sevilla, Jesús; Torrens, Marta; The NEURODEP Group (Frontiers, 2017)
    The association of cocaine use disorder (CUD) and comorbid major depressive disorder (MDD; CUD/MDD) is characterized by high prevalence and poor treatment outcomes. CUD/MDD may be primary (primary MDD) or cocaine-induced ...
  • Sola Llopis, Susana de; Torre Fornell, Rafael de la; Sánchez Benavides, Gonzalo; Benejam, Bessy; Cuenca Royo, Aida Ma, 1981-; Del Hoyo Soriano, Laura; Rodríguez, Joan; Catuara Solarz, Silvina, 1986-; Sánchez Gutiérrez, Judit; Dueñas-Espín, Iván, 1979-; Hernández, Gimena; Peña-Casanova, J. (Jordi); Langohr, Klaus; Videla, Sebastià; Blehaut, Henry; Farré Albaladejo, Magí; Dierssen, Mara; TESDAD Study Group (Frontiers, 2015)
    The recent prospect of pharmaceutical interventions for cognitive impairment of Down syndrome (DS) has boosted a number of clinical trials in this population. However, running the trials has raised some methodological ...
  • Torre Fornell, Rafael de la; De Sola Llopis, Susana; Xicota Vila, Laura, 1987-; Cuenca Royo, Aida Ma, 1981-; Rodriguez, Joan; Gomis González, Maria; Hernández, Gimena; Del Hoyo Soriano, Laura; Ozaita Mintegui, Andrés, 1969-; Dierssen, Mara; TESXF Study Group; Principe, Alessandro; Espadaler, Josep María; Roca, Laia; Del Hoyo Soriano, Laura; Farré Albaladejo, Magí; Fitó Colomer, Montserrat; León Jorba, Alba; Banea, Ovideo; Maldonado, Rafael, 1961-; Busquets Garcia, Arnau, 1985- (Elsevier, 2019)
    Background & aims: Despite the wide spectrum of experimental compounds tested in clinical trials, there is still no proven pharmacological treatment available for Fragile-X syndrome (FXS), since several targeted clinical ...
  • González, Débora; Torrens, Marta; Farré Albaladejo, Magí (Hindawi Publishing Corporation, 2015)
    BACKGROUND: 2C-B (Nexus) is one of the most widespread novel psychoactive substances. There is limited information about its pharmacological properties, and few studies in humans concern its acute and chronic effects. 2C-B ...
  • Papaseit Fontanet, Esther; Farré Albaladejo, Magí; Pérez Mañá, Clara; Torrens, Marta; Ventura, Mireia; Pujadas, Mitona; Torre Fornell, Rafael de la; González, Débora (Frontiers, 2018)
    2,5-dimethoxy-4-bromophenethylamine (2C-B) is a psychedelic phenylethylamine derivative, structurally similar to mescaline. It is a serotonin 5-hydroxytryptamine-2A (5-HT2A), 5-hydroxytryptamine-2B (5-HT2B), and ...
  • Pastor, Antonio; Rodríguez-Morató, Jose, 1987-; Olesti Muñoz, Eulàlia; Pujadas Bastardes, Mitona; Pérez Mañá, Clara; Khymenets, Olha, 1974-; Fitó Colomer, Montserrat; Covas Planells, Maria Isabel; Solà, Rosa; Motilva, Maria-José; Farré Albaladejo, Magí; Torre Fornell, Rafael de la (Elsevier, 2016)
    Hydroxytyrosol (HT) from olive oil, a potent bioactive molecule with health benefits, has a poor bioavailability, its free form (free HT) being undetectable so far. This fact leads to the controversy whether attained HT ...
  • Torres-Moreno, Mari Carmen; Papaseit Fontanet, Esther; Torrens, Marta; Farré Albaladejo, Magí (American Medical Association, 2018)
    IMPORTANCE: Cannabinoids have antispastic and analgesic effects; however, their role in the treatment of multiple sclerosis (MS) symptoms is not well defined. OBJECTIVE: To conduct a systematic review and meta-analysis to ...
  • Papaseit Fontanet, Esther; Pérez Mañá, Clara; Pérez-Acevedo, Ana Pilar; Hladun, Olga; Torres-Moreno, M. Carmen; Muga, Roberto; Torrens, Marta; Farré Albaladejo, Magí (Ivyspring International Publisher, 2018)
    Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical ...
  • Pardo Lozano, Ricardo; Farré Albaladejo, Magí; Yubero Lahoz, Samanta, 1985-; O'Mathuna, Brian; Torrens, Marta; Mustata, Cristina; Pérez Mañá, Clara; Langohr, Klaus; Cuyàs, Elisabet; Carbó Banús, Marcel·lí; Torre Fornell, Rafael de la (Public Library of Science (PLoS), 2012)
    The synthetic psychostimulant MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) acts as an indirect serotonin, dopamine, and norepinephrine agonist and as a mechanism-based inhibitor of the cytochrome P-450 2D6 (CYP2D6). ...
  • Fonseca Casals, Francina, 1972-; Torre Fornell, Rafael de la; Díaz, Laura; Pastor, Antonio; Cuyàs, Elisabet; Pizarro Lozano, Mª Nieves; Khymenets, Olha, 1974-; Farré Albaladejo, Magí; Torrens, Marta (Public Library of Science (PLoS), 2011)
    Although the efficacy of methadone maintenance treatment (MMT) in opioid dependence disorder has been well established, the influence of methadone pharmacokinetics in dose requirement and clinical outcome remains controversial. ...
  • Hernández Acosta, Astrid; Baños i Díez, Josep Eladi; Llop, Cristina; Farré Albaladejo, Magí (Public Library of Science (PLoS), 2014)
    Aim: Lack of knowledge concerning the nature of placebo and why it is necessary may influence the participation of patients in clinical trials. The objective of the present study is to review how placebo is described in ...
  • Reverter Branchat, Gemma; Bosch Colom, Jaume, 1954-; Vall, Jessica; Farré Albaladejo, Magí; Papaseit Fontanet, Esther; Pichini, Simona; Segura Noguera, Jordi (American Association for Clinical Chemistry, 2016)
    BACKGROUND: Although it is being increasingly applied, blood collection for drug testing in sport presents some logistic issues that complicate full applicability on a large scale. The use of dried blood spots (DBS) could ...
  • Moreno-Vicente, Raquel; Fernández-Nieva, Zuriñe; Navarro, Arantza; Gascón-Crespí, Irene; Farré Albaladejo, Magí; Igartua, Manuela; Hernández, Rosa María; Pedraz, José Luis (Elsevier, 2015)
    A bioanalytical method using high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated for simultaneous quantification of heroin, its main metabolites and naloxone. In addition, ...
  • Pérez Mañá, Clara; Papaseit Fontanet, Esther; Fonseca Casals, Francina, 1972-; Farré Martínez, Adriana; Torrens, Marta; Farré Albaladejo, Magí (Frontiers, 2018)
    Fentanyl, fentanyl analogs, and other new synthetic opioids (NSO) have burst onto the illegal drug market as new psychoactive substances (NPS). They are often sold as heroin to unsuspecting users and produce euphoria through ...
  • Martín-Peláez, Sandra; Mosele, Juana; Pizarro Lozano, Mª Nieves; Farràs Mañé, Marta; Torre Fornell, Rafael de la; Subirana Cachinero, Isaac; Pérez-Cano, Francisco José; Castañer, Olga; Solà, Rosa; Fernandez-Castillejo, Sara; Heredia, Saray; Farré Albaladejo, Magí; Motilva, Maria-José; Fitó Colomer, Montserrat (Springer, 2017)
    PURPOSE: To investigate the effect of virgin olive oil phenolic compounds (PC) alone or in combination with thyme PC on blood lipid profile from hypercholesterolemic humans, and whether the changes generated are related ...
  • Olesti Muñoz, Eulàlia; Pujadas Bastardes, Mitona; Papaseit Fontanet, Esther; Pérez Mañá, Clara; Pozo Mendoza, Óscar J., 1975-; Farré Albaladejo, Magí; Torre Fornell, Rafael de la (Oxford University Press, 2017)
    Increasing consumption has been observed among young people of new psychoactive substances, including synthetic cathinone derivatives. The most well known of these is mephedrone whose use has been related to acute intoxication ...
  • Ferro, P.; Ventura Alemany, Rosa; Pérez Mañá, Clara; Farré Albaladejo, Magí; Segura, Joan (Elsevier, 2016)
    Human Growth Hormone (hGH, somatotropin) is one of the relevant forbidden substances to be detected in sport drug testing. Since the appearance of recombinant hGH (rhGH) in the 80's, its expansion and availability through ...
  • Papaseit Fontanet, Esther; Pérez Mañá, Clara; Mateus Rodriguez, Julian Andrés; Pujadas Bastardes, Mitona; Fonseca Casals, Francina, 1972-; Torrens, Marta; Olesti Muñoz, Eulàlia; Torre Fornell, Rafael de la; Farré Albaladejo, Magí (Nature Publishing Group, 2016)
    Mephedrone (4-methylmethcathinone) is a novel psychoactive substance popular among drug users because it displays similar effects to MDMA (3,4-methylenedioxymethamphetamine, ecstasy). Mephedrone consumption has been ...
  • García Marchena, Nuria; Barrera, Marta; Mestre-Pintó, Juan Ignacio; Araos, Pedro; Serrano, Antonia; Pérez Mañá, Clara; Papaseit Fontanet, Esther; Fonseca Casals, Francina, 1972-; Ruiz, Juan Jesús; Rodríguez de Fonseca, Fernando; Farré Albaladejo, Magí; Pavón, Francisco Javier; Torrens, Marta (Public Library of Science (PLoS), 2019)
    Major depressive disorder (MDD) is the most prevalent comorbid mental disorder among people with substance use disorders. The MDD can be both primary and substance-induced and its accurate diagnosis represents a challenge ...
  • Cuyàs, Elisabet; Verdejo García, Antonio; Fagundo, Ana B.; Khymenets, Olha, 1974-; Rodríguez, Joan; Cuenca Royo, Aida Ma, 1981-; De Sola Llopis, Susana; Langohr, Klaus; Peña-Casanova, J. (Jordi); Torrens, Marta; Martín Santos, Rocío; Farré Albaladejo, Magí; Torre Fornell, Rafael de la (Public Library of Science (PLoS), 2011)
    This study is aimed to clarify the association between MDMA cumulative use and cognitive dysfunction, and the potential role of candidate genetic polymorphisms in explaining individual differences in the cognitive effects ...